Sahay Pranita, Asif Mohamed Ibrahime, Maharana Prafulla Kumar, Titiyal Jeewan S
Department of Ophthalmology, Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, New Delhi, India.
BMJ Case Rep. 2018 Sep 15;2018:bcr-2018-226498. doi: 10.1136/bcr-2018-226498.
We present two cases of culture-proven fungal keratitis on natamycin treatment which developed periocular erythema, oedema, burning sensation and pruritus within 48 hours of the addition of topical voriconazole. On clinical examination, periocular erythema with induration was noted. A diagnosis of orbital cellulitis was suspected, but the absence of pain and tenderness refuted the diagnosis on clinical grounds. A dermatology consultation was sought, and a diagnosis of periocular contact dermatitis with voriconazole was made. A skin patch test was performed with the same medication; however, it was negative. Topical voriconazole therapy was withdrawn, and the patient was prescribed cold compresses and oral antihistamine medication, to which they responded well.
我们报告了两例经培养证实的真菌性角膜炎患者,在接受那他霉素治疗期间,在加用局部伏立康唑后48小时内出现了眼周红斑、水肿、烧灼感和瘙痒。临床检查发现眼周有硬结性红斑。怀疑为眼眶蜂窝织炎,但缺乏疼痛和压痛在临床上排除了该诊断。寻求皮肤科会诊后,诊断为伏立康唑引起的眼周接触性皮炎。用相同药物进行了皮肤斑贴试验,结果为阴性。停用局部伏立康唑治疗,为患者开了冷敷和口服抗组胺药,患者对此反应良好。